Cigna Corp

CI
Delayed Nyse - 07/19 10:01:20 pm
173.69USD
-1.84%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales 48 111 133 612
EBITDA 5 540 11 595
Operating profit (EBIT) 4 854 8 811
Pre-Tax Profit (EBT) 3 581 7 575
Net income 2 637 5 268
P/E ratio 18,0x 12,8x
EPS ( $ ) 10,5 13,6
Dividend per Share ( $ ) 0,04 0,06
Yield 0,02% 0,04%
Reference price ( $ ) 189,920 173,690
Announcement Date 02/01/2019
11:00am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Debt 38 623 31 553
Finance - -
Operating income (EBITDA) 5 540 11 595
Leverage
(Debt/EBITDA)
6,97x 2,72x
Capital Expenditure 528 815
Book Value Per Share (BVPS) ( $ ) 108 123
Cash Flow per Share ( $ ) 15,4 24,1
Announcement Date 02/01/2019
11:00am
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 65 908 M $ -
Entreprise Value (EV) 97 461 M $ 92 200 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 12,8x 12,4x
Capitalization / Revenue 0,49x 0,47x
EV / Revenue 0,73x 0,69x
EV / EBITDA 8,41x 8,35x
Yield (DPS / Price) 0,04% 0,04%
Price to book (Price / BVPS) 1,42x 1,26x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 6,59% 6,50%
Operating Leverage (Delta EBIT / Delta Sales) 0,46x 0,73x
Net Margin (Net Profit / Revenue) 3,94% 3,86%
ROA (Net Profit / Asset) 2,88% 4,03%
ROE (Net Profit / Equities) 12,0% 13,3%
Rate of Dividend 0,46% 0,48%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0,61% 0,62%
Cash Flow / Sales 6,83% 4,80%
Capital Intensity (Assets / Sales) 1,37x 0,96x
Financial Leverage (Net Debt / EBITDA) 2,72x 2,25x
Price Earning Ratio
BNA & Dividende